Topic Editors

Dr. Allan J. Guimarães
Departamento de Microbiologia e Parasitologia, Instituto Biomédico, Universidade Federal Fluminense, Rio de Janeiro 24210-130, Brazil
Dr. Marcos de Abreu Almeida
Departamento de Microbiologia e Parasitologia, Instituto Biomédico, Universidade Federal Fluminense, Rio de Janeiro 24210-130, Brazil

Pathophysiology and Clinical Management of Fungal Infections

Abstract submission deadline
30 September 2026
Manuscript submission deadline
30 November 2026
Viewed by
2533

Topic Information

Dear Colleagues,

Fungal infections represent an escalating global health concern due to the rising prevalence of immunocompromised populations and the emerging threat of antifungal resistance. These infections range from superficial skin conditions to invasive, life-threatening systemic mycosis, affecting a diverse population globally but predominantly immunosuppressed individuals, including those with HIV/AIDS, cancer, or undergoing organ transplants. Understanding the pathophysiology of fungal infections is critical for developing targeted therapeutic strategies. Key areas of current research focus on the molecular and cellular processes that drive fungal pathogenicity, such as biofilm formation, and cellular differentiation processes, such as spore production and host invasion. Additionally, the role of the microbiome and host genetic factors in host–pathogen interactions and disease progression, and the modulation of immune responses hold paramount promise for novel therapeutic interventions. Clinical management remains challenging due to the lack of rapid and specific diagnosis, limited antifungal classes, and the rise of multidrug-resistant species. Therefore, advances in rapid diagnostics, such as molecular assays and biomarker-based tools, are critical for timely intervention. Therapeutically, there is growing interest in exploring combination antifungal regimens, drug repurposing, immunotherapies, and the development of new antifungal agents with novel mechanisms of action. We encourage submissions that provide insights into fungal biology, pathogenesis, diagnostic innovations, antifungal resistance mechanisms, and cutting-edge therapeutic advances, aiming to improve patient outcomes and expand our understanding and management of these complex infections.

Dr. Allan J. Guimarães
Dr. Marcos de Abreu Almeida
Topic Editors

Keywords

  • mycosis
  • pathogenesis
  • virulence factors
  • immune response
  • diagnosis
  • antifungals

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Journal of Fungi
jof
4.0 8.4 2015 19 Days CHF 2600 Submit
Microbiology Research
microbiolres
2.2 2.8 2010 20.2 Days CHF 1800 Submit
Microorganisms
microorganisms
4.2 7.7 2013 20 Days CHF 2700 Submit
Pathogens
pathogens
3.3 6.8 2012 14.1 Days CHF 2200 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (2 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
15 pages, 1169 KB  
Article
Fatty Acid Profiling Identification Method of Emerging Fungal Pathogen Candidozyma auris (Formally Candida auris)
by Thu Huynh, Flora Bohner, Adiyadolgor Turbat, György Sipos, Attila Gácser, Csaba Vágvölgyi, Tamás Papp, Mónika Varga and András Szekeres
J. Fungi 2026, 12(2), 130; https://doi.org/10.3390/jof12020130 - 11 Feb 2026
Viewed by 310
Abstract
The species Candidozyma auris (formerly known as Candida auris) can be subdivided into four major and two minor clades. It is considered an emerging multidrug-resistant pathogen that causes invasive outbreaks around the world. Therefore, the accurate identification of this species plays an [...] Read more.
The species Candidozyma auris (formerly known as Candida auris) can be subdivided into four major and two minor clades. It is considered an emerging multidrug-resistant pathogen that causes invasive outbreaks around the world. Therefore, the accurate identification of this species plays an important role in combating invasion and facilitating pathogenic management. In our study an optional identification method was developed considering the possibility of using cellular fatty acids (FAs) as a taxonomic and diagnostic tool. FAs were recorded in the collected C. auris strains, and the species characteristic components were determined. Within the isolates examined, the clades were also separated in the statistical analysis. Furthermore, FAs from strains belonging to clade I and II have been divided into two distinct clusters. In testing the performance of the method, all identified samples showed good matches with the established C. auris record in the database without misreading. Taken together, cellular fatty acids were investigated as potential discriminatory biomarkers. The results suggest that this approach can distinguish C. auris from related species and provides distinctive fatty acid profiles for the investigated C. auris clades. The present findings revealed the first report on the application of whole cell FA components as taxonomic features in C. auris. Full article
Show Figures

Figure 1

13 pages, 1367 KB  
Article
Construction of a Risk Assessment Model for Short-Term Mortality in Patients with Invasive Fungal Diseases Post-Cardiac Surgery Based on Multivariate Analysis
by Dong Wei, Qi Shen and Qian Zhai
Pathogens 2025, 14(11), 1116; https://doi.org/10.3390/pathogens14111116 - 3 Nov 2025
Viewed by 639
Abstract
To develop and validate a predictive model for assessing the risk of short-term mortality in patients with invasive fungal diseases (IFDs) following cardiac surgery. This retrospective study analyzed clinical data from patients diagnosed with postoperative IFDs in the cardiac surgical intensive care unit [...] Read more.
To develop and validate a predictive model for assessing the risk of short-term mortality in patients with invasive fungal diseases (IFDs) following cardiac surgery. This retrospective study analyzed clinical data from patients diagnosed with postoperative IFDs in the cardiac surgical intensive care unit (ICU) of Qilu Hospital of Shandong University (QLH), between January 2020 and December 2023. A total of 98 patients were included and divided into a non-survival group (n = 42) and a survival group (n = 56) based on 28-day mortality. Demographic, clinical, and postoperative parameters were collected. The Least Absolute Shrinkage and Selection Operator (LASSO) regression was used for variable selection, and selected variables were then entered into multivariate logistic regression to identify independent risk factors. A nomogram was developed, and its predictive performance was evaluated using the receiver operating characteristic (ROC) curve, decision curve analysis (DCA), and clinical impact curve (CIC). Multivariate logistic regression, following variable selection by LASSO, identified a history of smoking, an elevated SOFA score, mean arterial pressure (MAP) below 70 mmHg, and tachyarrhythmia as independent risk factors for short-term mortality in this cohort (p < 0.05). The prediction model demonstrated excellent discrimination, with an area under the ROC curve (AUC) of 0.886 (95% CI: 0.816–0.957). The calibration curve showed good agreement between predicted and observed outcomes, with a mean absolute error of 0.023. Decision curve analysis indicated a net clinical benefit across a threshold probability range of 0.1 to 0.87. The clinical impact curve confirmed a high concordance between predicted mortality and actual outcomes. A history of smoking, an elevated SOFA score, MAP below 70 mmHg, and tachyarrhythmia independently predict short-term mortality in patients with IFDs after cardiac surgery. Therefore, the nomogram constructed from these factors provides an accurate and clinically applicable tool for risk stratification. Full article
Show Figures

Figure 1

Back to TopTop